Main menu

Kathryn Horwitz and Jennifer Richer of the University of Colorado Health Sciences Center have been awarded US Patent No. 6,750,015, “Progesterone receptor-regulated gene expression and methods related thereto.”

According to its abstract, the patent discloses expression profiles of genes that are regulated by progesterone receptors, and particularly by progesterone receptor isoforms PR-A and PR-B. Methods for using such genes to identify progesterone receptor agonist and antagonist ligands are described.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.